Investor Relations
Nov 09, 2018
OPKO Health Reports Third Quarter 2018 Financial Results MORE >>
Nov 08, 2018
BioReference Laboratories Named as Preferred Laboratory with Horizon Healthcare Services MORE >>
Nov 08, 2018
OPKO Health to Announce Third Quarter 2018 Financial Results on November 9, 2018 MORE >>
Sep 14, 2018
OPKO Confirms Resumption of Common Stock Trading on Nasdaq MORE >>

Press Releases

All Releases
OPKO Health Reports Third Quarter 2018 Financial Results
Nov 09, 2018
Conference Call begins today at 4:15 p.m. Eastern Time MIAMI , Nov. 09, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) reports financial results and business highlights for the three months ended September 30, 2018 . Financial Highlights Net loss for the three months ended September 30,
BioReference Laboratories Named as Preferred Laboratory with Horizon Healthcare Services
Nov 08, 2018
MIAMI , Nov. 08, 2018 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc.  (BRL) , an  OPKO Health  (NASDAQ: OPK) company and the third largest clinical laboratory in the United States , will remain an in-network provider with Horizon Health Services, Inc.
OPKO Health to Announce Third Quarter 2018 Financial Results on November 9, 2018
Nov 08, 2018
MIAMI , Nov. 08, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to announce its operating and financial results for the three and nine months ended September 30, 2018 after the close of the U.S. financial markets on Friday, November 9, 2018 .
OPKO Confirms Resumption of Common Stock Trading on Nasdaq
Sep 14, 2018

MIAMI --(BUSINESS WIRE)--Sep. 14, 2018-- OPKO Health, Inc. (NASDAQ: OPK) is pleased to confirm that The Nasdaq Stock Market has lifted the trading suspension of OPKO’s shares. As noted previously, OPKO and 19 other defendants, including Dr. Phillip Frost , its CEO and Chairman, were named in a

OPKO Comments on Continued Nasdaq Halt of Trading of Common Stock
Sep 11, 2018

MIAMI --(BUSINESS WIRE)--Sep. 11, 2018-- OPKO Health, Inc. (NASDAQ:OPK) has had trading in its common stock halted by The Nasdaq Stock Market , and the exchange has advised OPKO that the halt will continue until the company responds (to Nasdaq’s satisfaction) to the exchange’s request for

OPKO Comments on SEC Complaint
Sep 07, 2018

MIAMI --(BUSINESS WIRE)--Sep. 7, 2018-- OPKO Health, Inc. (NASDAQ: OPK) provided the following comment on the lawsuit filed by the U.S. Securities and Exchange Commission earlier today. “OPKO learned today that the Securities and Exchange Commission has filed a lawsuit in the Southern District of

OPKO Initiates RAYALDEE Phase 2 Trial in Dialysis Patients
Sep 04, 2018

MIAMI , Sept. 04, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) has initiated a Phase 2 clinical trial to study the safety and efficacy of RAYALDEE ® as a new treatment for secondary hyperparathyroidism (SHPT) in adults with vitamin D insufficiency and stage 5 chronic kidney disease

OPKO Health’s BioReference Laboratories to Participate in the National Cancer Institute NCI-MATCH (Molecular Analysis for Therapy Choice) Phase II Clinical Trial
Aug 28, 2018

MIAMI , Aug. 28, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that BioReference Laboratories, Inc. (BRL), an OPKO Health company and the third largest clinical laboratory in the United States , has signed a collaboration agreement with the National Cancer Institute (NCI)

OPKO Health Reports Second Quarter 2018 Financial Results
Aug 07, 2018

Conference Call begins today at 4:30 p.m. Eastern Time MIAMI , Aug. 07, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) reports financial results and business highlights for the three months ended June 30, 2018 . Financial Highlights Net loss for the quarter decreased by 63% to $6.2 million

OPKO Health Completes Enrollment in Global Phase 3 Study of Somatrogon (hGH-CTP) in Growth Hormone Deficient Children
Aug 03, 2018

MIAMI , Aug. 03, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) has completed enrollment in the Company’s global pivotal Phase 3 study in growth hormone deficient children, evaluating a single weekly injection of its investigational long-acting human growth hormone product, somatrogon,

OPKO Health to Announce Second Quarter 2018 Financial Results on August 7, 2018
Aug 02, 2018

MIAMI , Aug. 02, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to announce its operating and financial results for the three and six months ended June 30, 2018 after the close of the U.S. financial markets on Tuesday, August 7, 2018 . OPKO’s senior management will provide a

OPKO Partner Vifor Fresenius Receives Marketing Approval for RAYALDEE in Canada
Jul 16, 2018

MIAMI , July 16, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) announced today that the Company’s partner Vifor Fresenius Medical Care Renal Pharma (VFMCRP) has received approval from Health Canada to market RAYALDEE ® in Canada for the treatment of secondary hyperparathyroidism (SHPT) in

OPKO Health Completes Enrollment in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes and Obesity
Jun 11, 2018

MIAMI , June 11, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) today announced it has completed enrollment of 110 subjects in a Phase 2b dose escalation trial of OPK88003 to treat type 2 diabetes and obesity.  OPK88003 is a once weekly injectable oxyntomodulin medicine with GLP-1 and

OPKO Plans to Address Draft Local Coverage Determination Published by Novitas Solutions for 4Kscore Test
May 18, 2018

MIAMI , May 18, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq:OPK) today announced that Novitas Solutions, Inc. issued a draft local coverage determination (LCD) for the 4Kscore test®. The draft LCD is a proposed non-coverage policy for the 4Kscore test for Medicare and, prior to its

OPKO Health Reports First Quarter 2018 Financial Results
May 08, 2018

Conference Call begins today at 4:30 p.m. Eastern Time MIAMI , May 08, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) reports financial results and business highlights for the three months ended March 31, 2018 . Financial Highlights Consolidated revenues for the three months ended March

OPKO Health to Announce First Quarter 2018 Financial Results on May 8, 2018
May 02, 2018

MIAMI , May 02, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) plans to announce its operating and financial results for the three months ended March 31, 2018 after the close of the U.S. financial markets on Tuesday, May 8, 2018 . OPKO’s senior management will provide a business update and

OPKO Health Appoints Geoff Monk General Manager at BioReference Laboratories
May 01, 2018

MIAMI , May 01, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) today announced the appointment of Geoff Monk as General Manager with overall responsibility for BioReference Laboratories (BRL), an OPKO Health company and the third largest clinical laboratory in the United States . Mr.

OPKO Health to Remain on the Tel Aviv Stock Exchange
Apr 27, 2018

MIAMI , April 27, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) announced today it intends to remain on the Tel Aviv Stock Exchange (TASE) and withdraw its request to voluntarily delist its common stock from the TASE.  The initial delisting request was made public by the Company in a Form

OPKO Health Enrolls First Patient in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes
Mar 23, 2018
MIAMI , March 23, 2018 (GLOBE NEWSWIRE) -- OPKO Health , Inc.  (NASDAQ:OPK) has enrolled the first patient in a Phase 2b dose escalation trial of OPK88003, a once-weekly oxyntomodulin therapy containing dual agonist activity towards GLP-1 and Glucagon receptors, to treat type 2 diabetes and
OPKO Health Announces Landmark Study Showing 4Kscore® Test is Strong Predictor of Prostate Cancer Mortality Published in European Urology
Mar 16, 2018
Study of 11,506 men shows that healthy men with an abnormal PSA and a low 4Kscore test result can be safely monitored rather than undergo prostate biopsy MIAMI , March 16, 2018 (GLOBE NEWSWIRE) --   OPKO Health, Inc. (NASDAQ:OPK) today announced that data from a landmark study of the 4Kscore® test
Displaying 1 - 20 of 366